胆道肿瘤患者的营养治疗共识

2021-06-09 中国抗癌协会肿瘤营养与支持治疗专业委员会 肿瘤代谢与营养电子杂志.2021.8(3):257-260.

胆道系统恶性肿瘤在世界范围内虽然不算常见,但其发病率逐年上升,且恶性程度较高。我国胆道系统恶性肿瘤的发病率也有逐年上升的趋势。胆管癌患者的预后均很差,因此,胆道系统恶性肿瘤的姑息和支持治疗尤为重要,其

中文标题:

胆道肿瘤患者的营养治疗共识

发布日期:

2021-06-09

简要介绍:

胆道系统恶性肿瘤在世界范围内虽然不算常见,但其发病率逐年上升,且恶性程度较高。我国胆道系统恶性肿瘤的发病率也有逐年上升的趋势。胆管癌患者的预后均很差,因此,胆道系统恶性肿瘤的姑息和支持治疗尤为重要,其主要目的是尽可能地提高生活质量、延长生存时间。肝门部胆管癌患者术后早期进食能够有效减少感染、腹胀和尿潴留等并发症的发生,加快患者术后康复。胆道恶性肿瘤营养治疗途径的选择原则与其他恶性肿瘤基本一致,但也有其特点:①胆道手术多限于上消化道,空肠以下肠管受影响较小。②对于术前存在营养不良,特别是合并中度以上梗阻性黄疸的患者,建议经口或经鼻空肠置管或者经T形管空肠置管途径肠内营养。③对于肝功能储备较差、行较大范围肝切除或严重梗阻性黄疸的患者,应积极行胆道内支架引流或行经皮肝穿刺胆道引流术进行胆道减压,尽快改善肝功能,促进营养物质代谢吸收。④经皮肝穿刺胆道引流(PTCD)是临床广泛应用的治疗恶性胆道梗阻的方法。

相关资料下载:
[AttachmentFileName(sort=1, fileName=胆道肿瘤患者的营养治疗共识_李薇.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e5ec81c0021a02a7, title=胆道肿瘤患者的营养治疗共识, enTitle=, guiderFrom=肿瘤代谢与营养电子杂志.2021.8(3):257-260., authorId=0, author=, summary=胆道系统恶性肿瘤在世界范围内虽然不算常见,但其发病率逐年上升,且恶性程度较高。我国胆道系统恶性肿瘤的发病率也有逐年上升的趋势。胆管癌患者的预后均很差,因此,胆道系统恶性肿瘤的姑息和支持治疗尤为重要,其, cover=https://img.medsci.cn/2021729/1627489141555_2020535.jpg, journalId=0, articlesId=null, associationId=1418, associationName=中国抗癌协会肿瘤营养与支持治疗专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed Jun 09 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>胆道系统恶性肿瘤在世界范围内虽然不算常见,但其发病率逐年上升,且恶性程度较高。我国胆道系统恶性肿瘤的发病率也有逐年上升的趋势。胆管癌患者的预后均很差,因此,胆道系统恶性肿瘤的姑息和支持治疗尤为重要,其主要目的是尽可能地提高生活质量、延长生存时间。肝门部胆管癌患者术后早期进食能够有效减少感染、腹胀和尿潴留等并发症的发生,加快患者术后康复。胆道恶性肿瘤营养治疗途径的选择原则与其他恶性肿瘤基本一致,但也有其特点:①胆道手术多限于上消化道,空肠以下肠管受影响较小。②对于术前存在营养不良,特别是合并中度以上梗阻性黄疸的患者,建议经口或经鼻空肠置管或者经T形管空肠置管途径肠内营养。③对于肝功能储备较差、行较大范围肝切除或严重梗阻性黄疸的患者,应积极行胆道内支架引流或行经皮肝穿刺胆道引流术进行胆道减压,尽快改善肝功能,促进营养物质代谢吸收。④经皮肝穿刺胆道引流(PTCD)是临床广泛应用的治疗恶性胆道梗阻的方法。</p> </div> </div> </div>, tagList=[TagDto(tagId=2871, tagName=胆道肿瘤)], categoryList=[CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2871, guiderKeyword=胆道肿瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5802, appHits=206, showAppHits=0, pcHits=835, showPcHits=5592, likes=1, shares=24, comments=3, approvalStatus=1, publishedTime=Sat Jul 31 22:52:04 CST 2021, publishedTimeString=2021-06-09, pcVisible=1, appVisible=1, editorId=1, editor=adminms, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 29 00:23:40 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 04:01:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=胆道肿瘤患者的营养治疗共识_李薇.pdf)])
胆道肿瘤患者的营养治疗共识_李薇.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191642, encodeId=36fc1191642db, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12ff5257106, createdName=147f42d5m31暂无昵称, createdTime=Wed Feb 09 23:45:42 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005218, encodeId=83cf100521816, content=很实用,非常受用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210805/1c8899d8095649df960fde930ec42932/5359751f8bf74062905614ca482b6bb3.jpg, createdBy=69b55564117, createdName=ms1000001855513458, createdTime=Wed Aug 04 21:57:55 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003632, encodeId=3050100363237, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/70bba8944cda4a9f961f152438bbef19/2242292829644005a34952b44e2c187e.jpg, createdBy=48fb4806846, createdName=Serendipity lai, createdTime=Thu Jul 29 19:34:35 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2022-02-09 147f42d5m31暂无昵称

    想学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191642, encodeId=36fc1191642db, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12ff5257106, createdName=147f42d5m31暂无昵称, createdTime=Wed Feb 09 23:45:42 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005218, encodeId=83cf100521816, content=很实用,非常受用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210805/1c8899d8095649df960fde930ec42932/5359751f8bf74062905614ca482b6bb3.jpg, createdBy=69b55564117, createdName=ms1000001855513458, createdTime=Wed Aug 04 21:57:55 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003632, encodeId=3050100363237, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/70bba8944cda4a9f961f152438bbef19/2242292829644005a34952b44e2c187e.jpg, createdBy=48fb4806846, createdName=Serendipity lai, createdTime=Thu Jul 29 19:34:35 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2021-08-04 ms1000001855513458

    很实用,非常受用!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191642, encodeId=36fc1191642db, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12ff5257106, createdName=147f42d5m31暂无昵称, createdTime=Wed Feb 09 23:45:42 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005218, encodeId=83cf100521816, content=很实用,非常受用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210805/1c8899d8095649df960fde930ec42932/5359751f8bf74062905614ca482b6bb3.jpg, createdBy=69b55564117, createdName=ms1000001855513458, createdTime=Wed Aug 04 21:57:55 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003632, encodeId=3050100363237, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/70bba8944cda4a9f961f152438bbef19/2242292829644005a34952b44e2c187e.jpg, createdBy=48fb4806846, createdName=Serendipity lai, createdTime=Thu Jul 29 19:34:35 CST 2021, time=2021-07-29, status=1, ipAttribution=)]
    2021-07-29 Serendipity lai

    很好

    0